Dysfunction of the serotonergic system is critically involved in a diverse range of diseases, which accumulatively affect at least 20% of the population. In our preliminary studies, we identified transcription factors that converted human fibroblasts to induced serotonergic (i5HT) neurons. The efficiency was significantly increased by p53 knockdown and appropriate cell culture conditions. At day 12 of reprogramming, 50% of the cells were Tuj1+ neurons and 25% were 5HT+ neurons. This epigenetic reprogramming was dependent on Tet proteins, a family of three DNA hydroxylases that critically regulate the epigenome. Knocking down each of the Tet genes abolished the epigenetic conversion. We hypothesize that p53, Tet proteins, and appropriate extracellular environment are critical for the direct conversion human fibroblasts to i5HT neurons. To test this hypothesis, we will identify the optimal transcription factor combinations, investigate how p53 knockdown induces Tet genes, and study how Tet proteins and reprogramming factors impact on the transcriptome to facilitate the transdifferentiation of human fibroblasts to i5HT neurons. We will also examine the impact of cell culture environment on the conversion and assess the survival and function of i5HT neurons transplanted in rat brains. The proposal will develop a robust method for the generation of patient-specific and subtype-specific i5HT neurons, which would enable basic research and drug discovery on serotonin-related disorders.

Public Health Relevance

Our preliminary studies identified ways to directly convert human fibroblasts to induced serotonergic neurons. The proposal aims to optimize the method by studying the molecular mechanism for the direct conversion. It will significantly help researchers generate patient- specific induced serotonergic neurons for various studies on serotonin-related disorders.

Agency
National Institute of Health (NIH)
Institute
Veterans Affairs (VA)
Type
Non-HHS Research Projects (I01)
Project #
5I01BX002452-06
Application #
9678186
Study Section
Cellular and Molecular Medicine (CAMM)
Project Start
2014-01-01
Project End
2022-03-31
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
VA Western New York Healthcare System
Department
Type
DUNS #
020653809
City
Buffalo
State
NY
Country
United States
Zip Code
14215
Li, Hong; Jiang, Houbo; Zhang, Boyang et al. (2018) Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells. J Parkinsons Dis 8:479-493
Zhong, Ping; Hu, Zhixing; Jiang, Houbo et al. (2017) Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations. Cell Rep 19:1033-1044
Xu, Zhimin; Chu, Xingkun; Jiang, Houbo et al. (2017) Induced dopaminergic neurons: A new promise for Parkinson's disease. Redox Biol 11:606-612
Feng, Jian (2016) Kinetic barriers in transdifferentiation. Cell Cycle 15:1019-20
Xu, Z; Jiang, H; Zhong, P et al. (2016) Direct conversion of human fibroblasts to induced serotonergic neurons. Mol Psychiatry 21:62-70
Jiang, Houbo; Xu, Zhimin; Zhong, Ping et al. (2015) Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons. Nat Commun 6:10100
Pu, Jiali; Frescas, David; Zhang, Baorong et al. (2015) Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification. Exp Biol Med (Maywood) 240:1065-70
Hu, Zhixing; Pu, Jiali; Jiang, Houbo et al. (2015) Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling. Stem Cells Dev 24:2591-604
Ren, Yong; Jiang, Houbo; Hu, Zhixing et al. (2015) Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons. Stem Cells 33:68-78
Tang, Lin; Zhang, Yue; Wen, Yonghong (2013) 2-[(Quinolin-8-yl-oxy)meth-yl]-1H-benzimid-a-zole monohydrate. Acta Crystallogr Sect E Struct Rep Online 69:o1838